PCV55 Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada von Lachaine, J., Charron, J.N., Gregoire, J.C., Hegele, R.A., Leiter, L.A.

Volltext

PSS5 Cost per Responder Analysis of Latanoprostene Bunod Compared to Prostaglandin Analogs for OPEN-Angle Glaucoma in Canada von Beauchemin, C., Charron, J.N., Mathurin, K., Jobin Gervais, K., Barbeau, M., Agoumi, Y.

Volltext

PCN87 COST-EFFECTIVNESS ANALYSIS OF DABRAFENIB PLUS TRAMETINIB AS ADJUVANT TREATMENT FOR BRAF V600 MUTATION-POSITIVE MELANOMA AFTER SURGICAL RESECTION IN CANADA- A SOCIETAL PERSPEC... von Stellato, D., Thabane, M., Beauchemin, C., Bornheimer, R., Charron, J.N., Lachaine, J., Mathurin, K., Delea, T.E.

Volltext

EE155 Economic Burden of Obstructive Hypertrophic Cardiomyopathy in France von Charron, P., Zema, C.L., Cotte, F.E., Juban, A., Schmidt, A., Krause, T., Hurst, M., Gonzalez, J., Trochu, J.N.

Volltext

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009–2019) von Adams, D., Cintas, P., Solé, G., Tard, C., Labeyrie, C., Echaniz-Laguna, A., Cauquil, C., Pereon, Y., Magy, L., Morales, R. Juntas, Antoine, J.C., Lagrange, E., Petiot, P., Mallaret, M., Francou, B., Guiochon-Mantel, A., Coste, A., Demarcq, O., Geffroy, C., Famelart, V., Rudant, J, Bartoli, M, Donal, E., Lairez, O., Eicher, J.C., Kharoubi, M., Oghina, S., Trochu, J.N., Inamo, J., Habib, G., Roubille, F., Hagège, A., Morio, F., Cariou, E., Adda, J., Slama, M.S., Charron, P., Algalarrondo, V., Damy, T., Attarian, S.

Volltext

Role of rRAB22b, an oligodendrocyte protein, in regulation of transport of vesicles from trans Golgi to endocytic compartments von Rodriguez-Gabin, A.G., Cammer, M., Almazan, G., Charron, M., Larocca, J.N.

Volltext

Molecular analysis of the monomeric GTP-binding proteins of oligodendrocytes von Burcelin, R., Rodriguez-Gabin, A.G., Charron, M.J., Almazan, G., Larocca, J.N.

Volltext